Citations

Clear

1792 citation(s) found for "Stephanie".

Upregulation of CD56 expression and T‐cell receptor (TCR)‐independent activation of T cells with aging
Lemster, Bonnie , Montag, David T. , Paat, John, Studenski, Stephanie A. , Vallejo, Abbe N. , Michel, Joshua J. , Newman, Anne B.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 22 | Issue: S1 | Pages: No page available

10.1096/fasebj.22.1_supplement.662.11 Get It

Degeneration of the thymus and severe contraction of the T‐cell repertoire with aging suggest that immune homeostasis in old age could be mediated by distinct effectors. Therefore we examined receptors expressed on T cells as they undergo senescence in vitro , and those displayed by circulating T cells during normal chronologic aging. Monitoring of T cells driven to senescence showed de novo induction of CD56, the prototypic receptor of NK cells. Analysis of fresh T cells in blood showed an age‐dependent induction of CD56. These unusual T cells expressed high levels of Bcl2, p16, and p53, and had limited, or completely lost, ability to undergo cell division; properties consistent with senescence. CD56 cross‐linking without TCR ligation on CD56 + T cells resulted in extensive protein phosphorylation, NFκB activation, and Bax down‐regulation. CD56 cross‐linking was also sufficient to drive production of various humoral factors. These data indicate that the immunologic environment in old age is functionally distinct, rather than a dysfunctional version of that seen at a young age. In view of the reported inefficiencies of TCR‐driven immunity with aging, elicitation of TCR‐independent immune cascades by CD56 + T cells provide new avenues for the development of alternative strategies to enhance protective immunity in the elderly. [Supported by NIH grants R01‐AG022379, R01‐AG023629, P20‐CA103730, and T35‐AG026778].
Abstract 181: What’s in the Black Box?: Describing Current Practice, Challenges, and Barriers of Cardiology and Palliative Care Collaboration
Mancarella, G, Wordingham, Sara E., Goodlin, Sara, Blume, Elizabeth D. , Cooper, Stephanie , Josephson, Richard , Cestoni, Abby, Hauptman, Paul J., Wells, Rachel D. , Dionne-Odom, James Nicholas , McIlvennan, Colleen Kelley , Goodlin, Sarah J. , Alexander, Karen P. , Maurer, Matthew, Hauptman, Paul J. , Kirkpatrick, James N , Bakitas, Marie , Swetz, Keith M.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | June 21, 2021 | Volume: 10 | Issue: suppl_3 | Pages: No page available

10.1161/circoutcomes.10.suppl_3.181 Get It

Background: Guidelines recommend involvement of palliative care (PC) for patients with cardiovascular (CV) disease and their families. Little is known about the current integration of PC and CV services. Research Objectives: Our national survey aimed to describe current practices and to identify benefits, challenges, and barriers with collaboration. Methods: Qualitative content analysis of open-response questions in an investigator-developed electronic survey study of CV and PC providers (MDs, NPs, PAs, and other allied health) using email listservs, social media, and crowdsourcing. Frequencies were tabulated using SAS statistical software. Results: Of 134 respondents, most were physicians (n=56, 57%) or advanced practice RNs or PAs (n=37, 28%), from 52 U.S. institutions, representing 33 states. The most common care for which PC was integrated were mechanical circulatory support, advanced heart failure, and heart transplantation; the least common care for which PC was integrated were TAVR, ECMO, and pulmonary hypertension. Integrated practice (n=80, 61%), PC identification of goals of care (n=20, 15%) and PC aid in patient/family communication (n=15, 11%) were the most commonly identified as positives in current practice. PC provider workforce (n=22, 16%), underutilization of PC referrals (n=20, 15%), late disease PC referral (n=19, 14%), and fundamental knowledge deficit of specialty scope (n=18, 14%) were most frequently identified as challenges. Other barriers specifically noted were underdeveloped health infrastructure and limited allocated resources (n=23,17%) and mis-/negative perception of services (n=15, 11%). Conclusion: PC and CV collaboration occurs for a high proportion of CV patients and is viewed as overwhelming positive, despite the challenges of limited PC specialists availability, underdeveloped healthcare infrastructure, limited understanding of specialty practice, and late referrals. Priorities includes increasing PC provider availability, expanding knowledge of PC services, educating providers on models of collaboration, and improving institutional support.
Reduced Acidity Cranberry Improves Glycemic Response in Persons with Metabolic Syndrome
Dahl, Rachel , Kristen, Bolstad, Googins, Sarah, Hunter, Stephanie , Mackay, Mackay, Vorsa, Nicholi , Wilson, Ted, Dahl, Rachel, Limburg, Paul J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.595.28 Get It

Persons with metabolic syndrome could benefit from improved fruit consumption and reduced caloric intake. A cranberry fruit containing reduced titratable acidity was developed and used to create a 27% reduced calorie cranberry juice (RCCBJ) containing less added sugar (74 Cal/240 ml) relative to the 110 Cal/240 ml industry standard cranberry juice (CBJ). Subjects were recruited for metabolic syndrome (n=18; 53 16 years; BMI=34.4 ± 3.9) and their metabolic response to CBJ and RCCBJ was evaluated in single cross‐over fashion. Plasma glucose for CBJ at 0‐, 30‐, 60‐, and 120‐min was 105.6±12.3, 149.5±22.6, 127.9±30.3, and 98.6±14.6 (mg/dl). Plasma glucose for RCCBJ was 104.6±13.3, 140.3±22.5, 116.0±27.23, and 100.4±13. Plasma insulin for CBJ at 0‐, 30‐, 60‐, and 120‐ min was 10.21±5.1, 41.5±22.6, 30.3±19.7, and 12.0± (µIU/ml). Plasma insulin for RCCBJ was 12.2±8.4, 34.8±21.6, 20.7±13.9, and 12.3±9.8. For CBJ and RCCBJ plasma glucose and insulin significantly increased relative to baseline at 30‐ and 60‐min. At 60 min RCCBJ glucose and insulin were significantly less than CBJ. Plasma adiponectin and glucagon like peptide‐1 responses were also measured for CBJ and RCCBJ at 0‐, 30‐, 60‐, and 120‐min. Reduced acidity cranberry fruit was associated with RCCBJ containing 33% fewer calories and a beneficial metabolic response in persons with metabolic syndrome.
Knowledge and Needs of Resident Physicians Regarding Osteoporosis: A Nationwide Survey of Residents
Crandall, Carolyn , Rodriguez, Tyler D, Elashoff, David , Kling, Juliana M. , Shifren, Jan L. , Skinner, Lisa J., Bauer, Douglas C. , Crandall, Carolyn J , Bauer, Douglas C , Kling, Juliana M , Chen, Lucia , Rodriguez, Tyler D., Faubion, Stephanie S.

Mayo Clinic

JBMR Plus | June 18, 2021 | Volume: 5 | Issue: 8 | Pages: No page available

10.1002/jbm4.10524 | PMID 34368610 Get It

ABSTRACTLarge‐scale studies have not addressed the knowledge level of US resident physicians regarding osteoporosis management. We gauged the knowledge level of family medicine, internal medicine, and obstetrics and gynecology resident physicians regarding osteoporosis management. In 2019, we sent an anonymous survey via e‐mail to all program directors of Accreditation Council for Graduate Medical Education–accredited residency programs in family medicine, internal medicine, and obstetrics and gynecology for distribution to resident physicians. Knowledge items assessed osteoporosis screening, diagnosis, and treatment. We received responses from 182 family medicine, 275 internal medicine, and 122 obstetrics and gynecology programs. Of 582 resident physician respondents, 31% were family medicine residents, 47% were internal medicine residents, and 21% were obstetrics and gynecology residents. Although 77% of respondents correctly selected the T‐score threshold for the diagnosis of osteoporosis among persons aged 50 years and older (−2.5), only 20% of respondents correctly identified minimal‐trauma hip fracture as being diagnostic of osteoporosis. One‐third of respondents correctly identified which medications were demonstrated in clinical trials to decrease hip fracture risk. Fifteen percent of respondents correctly identified that denosumab and alendronate are associated with osteonecrosis of the jaw; and 40% of respondents correctly identified that decline in bone density is more rapid after discontinuation of denosumab than after discontinuation of bisphosphonates. Less than half of resident physicians knew that bisphosphonate‐associated atypical femoral fractures are duration‐dependent. One‐quarter of respondents felt not at all prepared to manage osteoporosis. In this nationwide survey of resident physicians, knowledge regarding osteoporosis diagnosis and treatment was poor, with a striking lack of knowledge regarding the two most serious adverse effects of osteoporosis pharmacotherapy (osteonecrosis of the jaw and atypical femoral fractures). The undertreatment of osteoporosis is unlikely to improve without increased education of resident physicians. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium
Sadler, Brooke , Skidmore, Alex, Gewirtz, Jordan I. , Anderson, Richard C. E. , Ackerman, Laurie L. , Adelson, P. David , Albert, Gregory W. , Aldana, Philipp R. , Alden, Tord D. , Averill, Christine, Baird, Lissa , Bauer, David F. , Bethel-Anderson, Tammy, Bierbrauer, Karin S. , Bonfield, Christopher M. , Brockmeyer, Douglas L. , Chern, Joshua J. , Couture, Daniel E., Durham, Susan, Ellenbogen, Richard G. , Eskandari, Ramin , Fuchs, Herbert E., George, Timothy M., Greene, Stephanie , Gross, Naina L. , Guillaume, Daniel, Hankinson, Todd C. , Heuer, Gregory G. , Iantosca, Mark, Iskandar, Bermans J. , Jackson, Eric M. , Jea, Andrew, Keating, Robert F., Krieger, Mark D., Leonard, Jeffrey R. , Maher, Cormac O. , Mangano, Francesco T. , Mapstone, Timothy B., McComb, J. Gordon , McEvoy, Sean D., Meehan, Thanda, Muhlbauer, Michael S., Oakes, W. Jerry, Olavarria, Greg, O’Neill, Brent R., Ragheb, John , Shannon, Chevis N. , Smith, Jodi L. , Stone, Scellig , Tuite, Gerald F. , Wait, Scott D. , Wellons, John C. , Whitehead, William E. , Park, Tae Sung, Limbrick, David D. , Strahle, Jennifer M. , Skidmore, Alexander, Haller, Gabe , Ahmed, Raheel , Daniels, David J. , Dlouhy, Brian J , Grant, Gerald A. , Graupman, Patrick C. , Greenfield, Jeffrey P. , Guillaume, Daniel J., Johnston, James M. , Khan, Nickalus R. , Menezes, Arnold H. , Selden, Nathan R. W. , Shah, Manish N. , Limbrick, David D.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | June 18, 2021 | Volume: 28 | Issue: 2 | Pages: 167-175

10.3171/2020.12.peds20552 | PMID 34144521 Get It

OBJECTIVE Scoliosis is common in patients with Chiari malformation type I (CM-I)–associated syringomyelia. While it is known that treatment with posterior fossa decompression (PFD) may reduce the progression of scoliosis, it is unknown if decompression with duraplasty is superior to extradural decompression. METHODS A large multicenter retrospective and prospective registry of 1257 pediatric patients with CM-I (tonsils ≥ 5 mm below the foramen magnum) and syrinx (≥ 3 mm in axial width) was reviewed for patients with scoliosis who underwent PFD with or without duraplasty. RESULTS In total, 422 patients who underwent PFD had a clinical diagnosis of scoliosis. Of these patients, 346 underwent duraplasty, 51 received extradural decompression alone, and 25 were excluded because no data were available on the type of PFD. The mean clinical follow-up was 2.6 years. Overall, there was no difference in subsequent occurrence of fusion or proportion of patients with curve progression between those with and those without a duraplasty. However, after controlling for age, sex, preoperative curve magnitude, syrinx length, syrinx width, and holocord syrinx, extradural decompression was associated with curve progression > 10°, but not increased occurrence of fusion. Older age at PFD and larger preoperative curve magnitude were independently associated with subsequent occurrence of fusion. Greater syrinx reduction after PFD of either type was associated with decreased occurrence of fusion. CONCLUSIONS In patients with CM-I, syrinx, and scoliosis undergoing PFD, there was no difference in subsequent occurrence of surgical correction of scoliosis between those receiving a duraplasty and those with an extradural decompression. However, after controlling for preoperative factors including age, syrinx characteristics, and curve magnitude, patients treated with duraplasty were less likely to have curve progression than patients treated with extradural decompression. Further study is needed to evaluate the role of duraplasty in curve stabilization after PFD.
Early chemoprophylaxis for deep venous thrombosis does not increase the risk of hematoma expansion in patients presenting with spontaneous intracerebral hemorrhage
Laurent, Dimitri , Bardhi, Olgert , Kubilis, Paul , Corliss, Brian M. , Adamczak, Stephanie, Geh, Ndi, Vaziri, Sasha , Busl, Katharina M. , Bardhi, Olgert , Dodd, William , Fox, W Christopher

Mayo Clinic

Surgical Neurology International | June 14, 2021 | Volume: 12 | Issue: No issue available | Pages: 277

10.25259/sni_100_2021 | PMID 34221608 Get It

Background: Spontaneous intracerebral hemorrhage (ICH) is a significant cause of morbidity and mortality worldwide. The development of venous thromboembolism (VTE), including deep venous thrombosis or pulmonary embolism, is correlated with negative outcomes following ICH. Due to the risk of hematoma expansion associated with the use of VTE chemoprophylaxis, there remains significant debate about the optimal timing for its initiation following ICH. We analyzed the risk of early chemoprophylaxis on hematoma expansion following ICH. Methods: We performed a retrospective analysis of patients presenting with spontaneous ICH at single institution between 2011 and 2018. The rate of hematoma expansion was compared between patients that received early chemoprophylaxis (on admission) and those that received conventional chemoprophylaxis (>24 h). Results: Data for 235 patients were available for analysis. Eleven patients (7.5%) in the early prophylaxis cohort and seven patients (8.0%) in the conventional prophylaxis cohort developed VTE (P = 0.9). Hematoma expansion also did not differ significantly (early 19%, conventional 23%, P = 0.5). Conclusion: The use of early chemoprophylaxis against venous thromboembolic events following ICH appears safe in our patient population without increasing the risk of hematoma expansion. Given the increased risk of poor outcome in the setting of VTE, early VTE chemoprophylaxis should be considered in patients who present with ICH. Larger, prospective, and randomized studies are necessary to better elucidate the risk of early chemoprophylaxis and potential reduction in venous thromboembolic events.
Challenging the association of hepatitis C and pyoderma gangrenosum
Croitoru, David , Sibbald, Cathryn , Brooks, Stephanie G. , Piguet, Vincent , Croitoru, D , Sibbald, C , Piguet, V , Alavi, Afsáneh

Mayo Clinic

British Journal of Dermatology | June 9, 2021 | Volume: 185 | Issue: 5 | Pages: 1047-1048

10.1111/bjd.20566 | PMID 34105770 Get It

Senolytics reduce coronavirus-related mortality in old mice
Camell, Christina D. , Yousefzadeh, Matthew J. , Zhu, Yi , Prata, Larissa , Huggins, Matthew A. , Pierson, Mark , Zhang, Lei , O’Kelly, Ryan, Pirtskhalava, Tamar , Xun, Pengcheng , Ejima, Keisuke , Xue, Ailing, Tripathi, Utkarsh , Espíndola‐Netto, Jair Machado , Giorgadze, Nino, Atkinson, Elizabeth J. , Inman, Christina L., Johnson, Kurt O. , Cholensky, Stephanie H., Carlson, Timothy W. , O’Sullivan, M. Gerard , Jameson, Stephen C. , Meves, Alexander , Li, Ming , Prakash, Y. S. , Hamilton, Sara E. , Niedernhofer, Laura J. , Kirkland, James L. , Prata, Larissa G P Langhi , LeBrasseur, Nathan K , Khosla, Sundeep , O'Sullivan, M Gerard , Allison, David B , Jameson, Stephen C , Meves, Alexander , Prakash, Y S , Chiarella, Sergio E , Hamilton, Sara E , Tchkonia, T , Niedernhofer, Laura J , Kirkland, James L , Robbins, Paul D , Zhang, Lei , Zhu, Yi , O'Kelly, Ryan D., LeBrasseur, Nathan K. , Khosla, Sundeep , Allison, David B. , Chiarella, Sergio E. , Tchkonia, Tamar , Robbins, Paul D.

Mayo Clinic

Science | June 8, 2021 | Volume: 373 | Issue: 6552 | Pages: No page available

10.1126/science.abe4832 | PMID 34103349 Get It

Senescent cells exacerbate COVID-19 Cellular senescence is a state elicited in response to stress signals and is associated with a damaging secretory phenotype. The number of senescent cells increases with advanced age and this in turn drives age-related diseases. Camell et al. show that senescent cells have an amplified inflammatory response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (see the Perspective by Cox and Lord). This response is communicated to nonsenescent cells, suppressing viral defense mechanisms and increasing the expression of viral entry proteins. In old mice infected with a SARS-CoV-2–related virus, treatment with senolytics to reduce the senolytic cell burden reduced mortality and increased antiviral antibodies. Science , abe4832, this issue p. eabe4832 ; see also abi4474, p. 281
Massive Pulmonary Embolism Causing Cardiac Arrest Managed with Systemic Thrombolytic Therapy: A Case Report
Welle, Stephanie, Harrison, Michael F. , Welle, Stephanie R

Mayo Clinic

American Journal of Case Reports | June 7, 2021 | Volume: 22 | Issue: No issue available | Pages: No page available

10.12659/ajcr.931215 | PMID 34228699 Get It